These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6489520)

  • 21. Specific alpha-galactosidase inhibitors, N-methylcalystegines--structure/activity relationships of calystegines from Lycium chinense.
    Asano N; Kato A; Miyauchi M; Kizu H; Tomimori T; Matsui K; Nash RJ; Molyneux RJ
    Eur J Biochem; 1997 Sep; 248(2):296-303. PubMed ID: 9346281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibition of glycosidases by aldonolactones.
    Levvy GA; Snaith SM
    Adv Enzymol Relat Areas Mol Biol; 1972; 36():151-81. PubMed ID: 4563427
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of mouse tumor metastasis with nojirimycin-related compounds.
    Tsuruoka T; Fukuyasu H; Ishii M; Usui T; Shibahara S; Inouye S
    J Antibiot (Tokyo); 1996 Feb; 49(2):155-61. PubMed ID: 8621356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The common identity of five glycosidases in human liver.
    Chester MA; Hultberg B; Ockerman PA
    Biochim Biophys Acta; 1976 Apr; 429(2):517-26. PubMed ID: 1260036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of leukocyte and plasma methylumbelliferyl-alpha-L-iduronide iduronidase.
    Den Tandt WR; Scharpe S
    Biochem Med Metab Biol; 1989 Feb; 41(1):18-24. PubMed ID: 2713148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of beta-glucuronidase by chlorinated hydroquinones and benzoquinones.
    Ahlborg UG; Manzoor E; Thunberg T
    Arch Toxicol; 1977 Jun; 37(2):81-7. PubMed ID: 327981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The kinetics of hydrolysis of synthetic glucuronic esters and glucuronic ethers by bovine liver and Escherichia coli beta-glucuronidase.
    Tomasić J; Keglević D
    Biochem J; 1973 Aug; 133(4):789-95. PubMed ID: 4584027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structural basis of the inhibition of human glycosidases by castanospermine analogues.
    Winchester BG; Cenci di Bello I; Richardson AC; Nash RJ; Fellows LE; Ramsden NG; Fleet G
    Biochem J; 1990 Jul; 269(1):227-31. PubMed ID: 2115770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human alpha-L-iduronidase. II. Comparative biochemical and immunologic properties of the purified low and high uptake forms.
    Schuchman EH; Guzman NA; Takada G; Desnick RJ
    Enzyme; 1984; 31(3):166-75. PubMed ID: 6734578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies.
    Clements PR; Brooks DA; McCourt PA; Hopwood JJ
    Biochem J; 1989 Apr; 259(1):199-208. PubMed ID: 2470345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of uronic-noeurostegine--a potent bacterial β-glucuronidase inhibitor.
    Rasmussen TS; Koldsø H; Nakagawa S; Kato A; Schiøtt B; Jensen HH
    Org Biomol Chem; 2011 Oct; 9(22):7807-13. PubMed ID: 21952673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucopolysaccharidosis type I subtypes. Presence of immunologically cross-reactive material and in vitro enhancement of the residual alpha-L-iduronidase activities.
    Schuchman EH; Desnick RJ
    J Clin Invest; 1988 Jan; 81(1):98-105. PubMed ID: 3121676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct demonstration of binding of a lysosomal enzyme, alpha-L-iduronidase, to receptors on cultured fibroblasts.
    Rome LH; Weissmann B; Neufeld EF
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2331-4. PubMed ID: 287076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a mechanism for introducing acid hydrolases into liver lysosomes that is independent of mannose 6-phosphate recognition? Evidence from I-cell disease.
    Owada M; Neufeld EF
    Biochem Biophys Res Commun; 1982 Apr; 105(3):814-20. PubMed ID: 6807313
    [No Abstract]   [Full Text] [Related]  

  • 35. Alpha-rhamnosidase inhibitory activities of polyhydroxylated pyrrolidine.
    Kim JH; Curtis-Long MJ; Seo WD; Lee JH; Lee BW; Yoon YJ; Kang KY; Park KH
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4282-5. PubMed ID: 16039852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect on human liver glycosidases and short syntheses of 1 alpha,2 alpha,6 alpha,7 alpha,7a beta-1,2,6,7-tetrahydroxypyrrolizidine from D-glycero-D-gulo-heptono-1,4-lactone.
    Collin WF; Fleet GW; Haraldsson M; Cenci di Bello I; Winchester B
    Carbohydr Res; 1990 Jul; 202():105-16. PubMed ID: 2224885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Irreversible α-l-Iduronidase Inhibitors and Activity-Based Probes.
    Artola M; Kuo CL; McMahon SA; Oehler V; Hansen T; van der Lienden M; He X; van den Elst H; Florea BI; Kermode AR; van der Marel GA; Gloster TM; Codée JDC; Overkleeft HS; Aerts JMFG
    Chemistry; 2018 Dec; 24(71):19081-19088. PubMed ID: 30307091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of calystegines isolated from edible fruits and vegetables on mammalian liver glycosidases.
    Asano N; Kato A; Matsui K; Watson AA; Nash RJ; Molyneux RJ; Hackett L; Topping J; Winchester B
    Glycobiology; 1997 Dec; 7(8):1085-8. PubMed ID: 9455909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A-72363 A-1, A-2, and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192, II. Biological activities.
    Kawase Y; Takahashi M; Takatsu T; Arai M; Nakajima M; Tanzawa K
    J Antibiot (Tokyo); 1996 Jan; 49(1):61-4. PubMed ID: 8609088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and properties of alpha-D-mannosidase from Medicago sativa L.
    De Prijcker J; Vervoort A; De Bruyne C
    Eur J Biochem; 1974 Sep; 47(3):561-6. PubMed ID: 4215656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.